As the industry shifts towards precision nutrition, Streptococcus thermophilus has emerged as a cornerstone in both the functional food and clinical probiotic sectors. Unlike many other lactic acid bacteria, this thermophilic species demonstrates exceptional acid and bile tolerance, making it an ideal candidate for gastrointestinal health and dairy fermentation.
Procurement teams worldwide are increasingly seeking suppliers who offer high-colony-forming-unit (CFU) consistency. Our manufacturing process utilizes state-of-the-art bioreactor technology to ensure peak strain stability, meeting the stringent regulatory demands of the European EFSA and US FDA markets.
The future of Streptococcus thermophilus lies in synergistic combinations. We are currently mapping the genetic resilience of our proprietary strains to improve post-biotic delivery systems. Our research pipeline focuses on:
Our stabilized powder formulations are engineered for 24 months of activity when stored under cool, dry conditions, backed by accelerated stability test data.
Yes, we offer white-paper technical consultations, including compatibility testing with excipients and guidance on processing temperatures.
